Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Verastem, Inc. - Common Stock
(NQ:
VSTM
)
5.840
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verastem, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
S&P 500 Rises 100 Points; Nasdaq Up 3%
↗
October 04, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing more than 300 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
October 04, 2022
Gainers
Via
Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
↗
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.
Via
Benzinga
RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm
↗
June 07, 2022
Via
Benzinga
Recap: Verastem Q4 Earnings
↗
March 28, 2022
Verastem (NASDAQ:VSTM) reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
October 04, 2022
On Tuesday, 44 companies hit new 52-week lows.
Via
Benzinga
Nasdaq Surges 350 Points; Crude Oil Rises Sharply
↗
October 04, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite climbing more than 350 points on Tuesday.
Via
Benzinga
Verastem Oncology Announces RAMP VS-6766 Clinical Trials and Corporate Updates
October 04, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
August 08, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 07, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Provides Update on RAMP 201 Study Evaluating VS-6766 ± Defactinib in Low-Grade Serous Ovarian Cancer
June 06, 2022
From
Verastem Oncology
Via
Business Wire
7 Cheap Biotech Stocks to Buy Now
↗
May 19, 2022
These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains.
Via
InvestorPlace
Verastem Oncology Awarded Pancreatic Cancer Action Network’s First Therapeutic Accelerator Award to Evaluate the Combination of VS-6766 and Defactinib in Front-Line Metastatic Pancreatic Cancer
May 18, 2022
From
Verastem Oncology
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 16, 2022
Via
Benzinga
Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress
May 09, 2022
From
Verastem Oncology
Via
Business Wire
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
↗
April 21, 2022
The FDA aims to put the PI3K inhibitor drug class under a more stringent regulatory scope as the inhibitor has demonstrated substantial toxicity.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 14, 2022
Gainers
Via
Benzinga
51 Biggest Movers From Thursday
↗
April 18, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via
Benzinga
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2022
From
Verastem Oncology
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
↗
April 14, 2022
Upgrades
Via
Benzinga
Verastem Oncology's Return On Capital Employed Insights
↗
March 29, 2022
According to data from Benzinga Pro, during Q4, Verastem Oncology's (NASDAQ:VSTM) reported sales totaled $545.00 thousand. Despite a 27.67% increase in earnings, the company posted a loss of $16.48...
Via
Benzinga
Verastem Announces $150M Debt Financing To Support VS-6766, Defactinib Development
↗
March 28, 2022
Verastem Oncology Inc (NASDAQ: VSTM) entered into a credit facility with Oxford Finance LLC for
Via
Benzinga
Verastem Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
March 28, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors
March 28, 2022
From
Verastem Oncology
Via
Business Wire
Verastem Oncology Names Preeminent Oncology Researcher Channing Der, PhD, to its Scientific Advisory Board
March 24, 2022
From
Verastem Oncology
Via
Business Wire
87 Biggest Movers From Yesterday
↗
March 10, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to...
Via
Benzinga
Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why
↗
March 09, 2022
Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside. Analyst...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2022
↗
March 09, 2022
Upgrades Roth Capital upgraded the previous rating for Hudson Technologies Inc (NASDAQ:HDSN) from Neutral to Buy. For the fourth quarter, Hudson Technologies had an EPS of $0.13,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
March 07, 2022
On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 25, 2022
Gainers Surgalign Holdings (NASDAQ:SRGA) ...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
